All the news Showing 10 of 690 articles from: Treatment issuesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Bacterial infection of the heart on the rise among people with hepatitis C in United States Keith Alcorn / 23 June 2020 Diagnoses of infective endocarditis, a life-threatening bacterial infection of the heart valves, have become more common over the past ten years among people with hepatitis C and people with opioid use disorder ... Increasing access to hepatitis C treatment in Ukraine MSF / 09 June 2020 COVID-19 in chronic liver disease: advanced cirrhosis greatly raises risk of death Keith Alcorn / 22 May 2020 People with chronic liver disease admitted to hospital with COVID-19 are dying at a much higher rate than the rest of the population, figures collated by liver specialists in Europe, Asia and ... Weight gain after hepatitis C cure is common Keith Alcorn / 19 May 2020 Substantial weight gain is common after hepatitis C cure, an analysis of a large cohort shows, and around one in five people with normal body weight became overweight within two years, US ... Short-course treatment for recent hepatitis C: some courses may be too short Keith Alcorn / 07 May 2020 An eight-week course of grazoprevir/elbasvir (Zepatier) achieved a high cure rate in people recently infected with hepatitis C, but another study found that a six-week course of sofosbuvir/velpatasvir (Epclusa) resulted in an inferior ... Hepatitis C treatment in adolescents and young people late but successful, Spanish study shows Keith Alcorn / 05 May 2020 Treatment for hepatitis C was highly effective in clearing the virus in young people co-infected with HIV and hepatitis C through vertical infection, despite advanced fibrosis in one-third, Spanish researchers report in the ... Directly observed treatment for hepatitis C highly effective in people who inject drugs Keith Alcorn / 14 April 2020 Directly observed treatment for hepatitis C achieved a very high cure rate in people who inject drugs, an Austrian study carried out in pharmacies and drugs projects offering opioid substitution therapy has reported. The ... FDA OKs Gilead’s paediatric hep C drug Pharma Times / 25 March 2020 Hepatitis C treatment and prevention failing to reach people most affected Keith Alcorn / 25 February 2020 Major gaps in harm reduction and treatment provision for people who inject drugs jeopardise the achievement of global targets for hepatitis C elimination by 2030, a review of hepatitis C treatment and ... Half of people who inject drugs in Middle East have hepatitis C Keith Alcorn / 24 February 2020 Half of people who inject drugs in the Middle East and north Africa have been infected with hepatitis C, and researchers from Weill Cornell Medicine Qatar estimate that around 221,000 people who ... ← Prev1...45678...69Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Transmission and prevention Diagnosis and monitoring Disease course and symptoms HCV and coinfections Living with HCV Treatment issues Side effects Therapies Liver transplants Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds